Mobarik Bilal

Introduction

Mobarik Bilal, an innovative inventor based in Montreal, Canada, has made significant contributions to the pharmaceutical field with his groundbreaking work on loxapine film oral dosage forms. His invention addresses the urgent need for effective treatments for patients experiencing acute agitation associated with schizophrenia and bipolar 1 disorder.

Latest Patents

Mobarik holds one patent for his inventive loxapine film oral dosage form. This formulation encompasses loxapine salt, free base, or prodrug, which is designed to be effectively delivered through oral transmucosal means. The film incorporates various beneficial components, including a sweetener, refreshing agent, antioxidant, pH stabilizer, penetration enhancer, mucoadhesive agent, and plasticizer. This innovative approach not only facilitates a rapid onset of relief for patients but also minimizes potential pulmonary health risks, ensuring safer treatment alternatives.

Career Highlights

Mobarik Bilal is associated with Intelgenx Corporation, a company known for its dedication to developing innovative pharmaceutical products. His work at Intelgenx has solidified his reputation as a key player in the development of advanced drug delivery systems that enhance patient care and efficacy.

Collaborations

Throughout his career, Mobarik has collaborated with notable colleagues such as Rodolphe Obeid and Nadine Paiement. These partnerships have contributed to the development and enhancement of his patent, showcasing the value of teamwork in driving innovation within the pharmaceutical industry.

Conclusion

Mobarik Bilal's contributions to the field of pharmaceuticals, particularly with his loxapine film oral dosage form, are a testament to the power of innovation in addressing critical healthcare challenges. His dedication and collaborative efforts at Intelgenx Corporation emphasize the importance of continued research and development in improving patient outcomes through novel therapeutic approaches.